Correlation Between Kezar Life and Oncolytics Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Kezar Life and Oncolytics Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kezar Life and Oncolytics Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kezar Life Sciences and Oncolytics Biotech, you can compare the effects of market volatilities on Kezar Life and Oncolytics Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kezar Life with a short position of Oncolytics Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kezar Life and Oncolytics Biotech.

Diversification Opportunities for Kezar Life and Oncolytics Biotech

0.68
  Correlation Coefficient

Poor diversification

The 3 months correlation between Kezar and Oncolytics is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Kezar Life Sciences and Oncolytics Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oncolytics Biotech and Kezar Life is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kezar Life Sciences are associated (or correlated) with Oncolytics Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oncolytics Biotech has no effect on the direction of Kezar Life i.e., Kezar Life and Oncolytics Biotech go up and down completely randomly.

Pair Corralation between Kezar Life and Oncolytics Biotech

Considering the 90-day investment horizon Kezar Life Sciences is expected to generate 0.93 times more return on investment than Oncolytics Biotech. However, Kezar Life Sciences is 1.07 times less risky than Oncolytics Biotech. It trades about -0.03 of its potential returns per unit of risk. Oncolytics Biotech is currently generating about -0.34 per unit of risk. If you would invest  773.00  in Kezar Life Sciences on August 27, 2024 and sell it today you would lose (26.00) from holding Kezar Life Sciences or give up 3.36% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Kezar Life Sciences  vs.  Oncolytics Biotech

 Performance 
       Timeline  
Kezar Life Sciences 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Kezar Life Sciences are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating basic indicators, Kezar Life reported solid returns over the last few months and may actually be approaching a breakup point.
Oncolytics Biotech 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Oncolytics Biotech are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent fundamental indicators, Oncolytics Biotech may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Kezar Life and Oncolytics Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Kezar Life and Oncolytics Biotech

The main advantage of trading using opposite Kezar Life and Oncolytics Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kezar Life position performs unexpectedly, Oncolytics Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oncolytics Biotech will offset losses from the drop in Oncolytics Biotech's long position.
The idea behind Kezar Life Sciences and Oncolytics Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Other Complementary Tools

Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Content Syndication
Quickly integrate customizable finance content to your own investment portal